Mitolactol chemotherapy for malignant melanoma: a phase II study.
Malden LT, Coates AS, Milton GW, McCarthy WH, Levi JA, Woods RL, Byrne MJ, Reynolds PM, Fox RM, Hedley DW, et al.
Malden LT, et al. Among authors: coates as.
Cancer Treat Rep. 1984 Jul-Aug;68(7-8):1045-6.
Cancer Treat Rep. 1984.
PMID: 6744338